Bibliography
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25
- Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337-41
- Leeson PD, Davis AM, Steele J. Drug-like properties: guiding principles for design – or chemical prejudice? Drug Discov Today 2004;1:189-95
- Lajiness MS, Vieth M, Erickson J. Molecular properties that influence oral drug-like behaviour. Curr Opin Drug Discov Dev 2004;7:470-7
- Hann, MM, Oprea TI. Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 2004;8:255-63
- Gleeson MP. Generation of a Set of Simple, interpretable ADMET rules of thumb. J Med Chem 2008;51:817-34
- Wenlock MC, Austin RP, Barton P, A comparison of physiochemical property profiles of development and marketed oral drugs. J Med Chem 2003;46:1250-6
- Hopkins AL. Ligand efficiency: a useful metric for lead selection. Drug Discov Today 2004;9:430-31
- Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007;6:881-90
- Keserü G, Makara G. The influence of lead discovery strategies on the properties of drug candidates. Nat Rev Drug Discov 2009;8:203-12
- Hughes JD, Blagg J, Price DA, Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 2008;18:4872-5
- Hann MM, Leach AR, Harper G. Molecular complexity and its impact on the probability of finding leads for drug. Discov J Chem Inf Comput Sci 2001;41:856-64
- Teague SJ, Davis AM, Leeson PD, Oprea T. The design of lead like combinatorial libraries. Angew Chem Int Ed 1999;38:3743-8
- Li D, Kerns EH. Application of pharmaceutical profiling assays for optimization of druglike properties. Curr Opin Drug Discov Dev 2005;8:495-504
- Smith DA, Schmid EF. Drug withdrawals and the lessons within. Curr Opin Drug Discov Dev 2006;9(1):38-46
- de Lange EC, Danhof M. Considerations in the use of CSF pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 2002;41:691-703
- Highlights from the Society for Medicines Research symposium held in London on December 2, 1999. Drug News Perspect 1999;12(10):647-52
- DRUGDEX: Drug and Pharmaceutical Information, Thomson Reuters Copyright© all rights reserved; 2009
- Burstein ES, Ma J, Wong S, Intrinsic efficacy of antipsychotics at Human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 Partial Agonist. J Pharmacol Exp Ther 2005;315:1278-87